Status:
COMPLETED
Study of Empathy in MS
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Brief Summary
Multiple sclerosis is a chronic inflammatory disease of the central nervous system whose exact etiology remains unclear, underpinned by multiple pathophysiological mechanisms, and is a cause of signif...
Detailed Description
Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects more than 2.8 million people worldwide and whose diagnosis is most often made around the age of 30. Its ...
Eligibility Criteria
Inclusion
- Patient aged 18 to 60
- Follow-up for multiple sclerosis meeting the revised McDonalds diagnostic criteria of 2017.
- Patient not objecting to participation in the research.
Exclusion
- NA
Key Trial Info
Start Date :
July 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05332951
Start Date
July 4 2022
End Date
December 19 2022
Last Update
February 2 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Pitié Salpêtrière
Paris, France
2
Hôpital Saint Antoine
Paris, France